β³ Fetching live dividend data...
Home βΊ Calculator βΊ AXIM Dividend Calculator 2026
AXIM Biotechnologies, Inc. Β· OTC
Price: $0.00 Β· Annual div: $2.00/share Β· Frequency: quarterly Β· Payout ratio: 50% Β· Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in AXIM β $1.760341573626314e+26M in 10 years Β· $14,647,541,800,851,343,000,000,000,000,000.00/month
AXIM Biotechnologies, Inc. specializes in the creation and distribution of advanced diagnostic solutions for healthcare, focusing on critical areas such as SARS-CoV-2 (COVID-19), ocular health, and cancer treatment. The company is currently developing rapid diagnostic assays that quantify functional neutralizing antibodies, which are essential for preventing the SARS-CoV-2 virus from attaching to human cells. Additionally, it offers serological diagnostic tests designed to detect neutralizing antibodies, thereby assessing the body's adaptive immune response to the virus, and is developing tests to identify inflammation biomarkers for the effective management of COVID-19 patients. For eye health, AXIM is pioneering quick, quantitative tear tests to measure Matrix metalloproteinase-9, an inflammatory marker associated with dry eye disease. In its oncology pipeline, the firm is advancing SBI-183, an anti-metastatic compound engineered to inhibit tumor cell growth and block the spread of cancer, as well as SPX-1009, another anti-metastatic therapy aimed at determining the levels of quiescin sulfhydryl oxidase I. Established in 2010, the company was formerly known as Axim International Inc. before officially changing its name to AXIM Biotechnologies, Inc. in July 2014, and it is headquartered in San Diego, California.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. Β· Privacy Policy
Ready to invest? Open AXIM position with:
Real after-tax yield depends on where you live and how you hold AXIM.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| πΊπΈ Roth IRA / 401k | 0% | 66666.67% | 66663.87% | $6,666,667 / yr |
| πΊπΈ US Taxable (15%) β | 15% | 56666.67% | 56663.87% | $5,666,667 / yr |
| πΊπΈ US Taxable (20%) | 20% | 53333.34% | 53330.54% | $5,333,334 / yr |
| π¬π§ UK ISA | 0% | 66666.67% | 66663.87% | $6,666,667 / yr |
| π¬π§ UK Taxable | 8.75% | 60833.34% | 60830.54% | $6,083,334 / yr |
| π¨π¦ TFSA | 0% | 66666.67% | 66663.87% | $6,666,667 / yr |
| π¨π¦ CA Taxable | 25% | 50000.00% | 49997.20% | $5,000,000 / yr |
| π¦πΊ Super (pension) | 15% | 56666.67% | 56663.87% | $5,666,667 / yr |
| π¦πΊ AU Taxable | 30% | 46666.67% | 46663.87% | $4,666,667 / yr |
| π©πͺ DE Taxable | 26.375% | 49083.34% | 49080.54% | $4,908,334 / yr |
| π«π· FR Taxable | 30% | 46666.67% | 46663.87% | $4,666,667 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr Β· πΊπΈ US Taxable (15%) Β· static projection (no growth assumed).
AXIM pays quarterly β 4 times per year. Next ex-div: TBD.
How AXIM compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024β2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for AXIM sourced from FMP /financial-growth endpoint β real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Buy | 2024-01-30 | 1,086,216 | β | β | ||
| A-Award | 2024-03-15 | 250,000 | $0.01 | $2.5K | ||
| A-Award | 2024-03-15 | 7,837,500 | $0.02 | $156.8K | ||
| A-Award | 2024-03-15 | 35,000 | $0.01 | $350.00 | ||
| A-Award | 2024-03-15 | 35,000 | $0.01 | $350.00 | ||
| A-Award | 2024-03-15 | 35,000 | $0.01 | $350.00 | ||
| A-Award | 2024-03-15 | 35,000 | $0.01 | $350.00 | ||
| A-Award | 2024-03-15 | 53,500 | $0.02 | $1.1K | ||
| A-Award | 2024-03-15 | 1 | $0.02 | β | ||
| Other | 2023-05-23 | 2,000,000 | $0.02 | $40.0K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores β lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the AXIM dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer β
AXIM Biotechnologies, Inc. (AXIM) is currently trading at $0.00, 100% below its 52-week high. The current dividend yield is 66666.67% based on an annual payout of $2.00 per share.
AXIM Biotechnologies, Inc. (AXIM) is a healthcare stock currently trading at $0.00 with a dividend yield of 66666.67%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only β not financial advice.
News aggregated from public sources via Finnhub & RSS. For informational purposes only.
Real users. No sign-up required to leave a review.
βFinally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.β
βI've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly β $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.β
βReally solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.β
βAs someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.β
βThe Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.β
Reviews reflect users' personal experiences. Not financial advice.
Leave a review βIf DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
β±οΈ Takes 30 seconds Β· No signup Β· Free forever